(November 8, 2023, 9:48 AM EST) -- WASHINGTON, D.C. — A bid for review of a decision by the Patent Trial and Appeal Board that confirmed as patentable two claims of an improved treatment for pterygium was rejected Nov. 7 by the Federal Circuit U.S. Court of Appeals on grounds that the appellant failed to establish an injury in fact....